Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Autophagy|April 22, 2011
A comprehensive siRNA screen for kinases that suppress macroautophagy in optimal growth conditionsPiotr Szyniarowski, Elisabeth Corcelle-Termeau, Thomas Farkas, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2013
ErbB2 upregulates the Na+,HCO3(-)-cotransporter NBCn1/SLC4A7 in human breast cancer cells via Akt, ERK, Src, and Kruppel-like factor 4Andrej Gorbatenko, Christina W Olesen, Nina Mørup, et al.
Cancer Research|August 4, 2004
Sensitization to the lysosomal cell death pathway upon immortalization and transformationNicole Fehrenbacher, Mads Gyrd-Hansen, Birgit Poulsen, et al.
STAR Protocols|November 17, 2023
Quantification of cell death and proliferation of patient-derived ovarian cancer organoids through 3D imaging and image analysisAikaterini Skorda, Anna Røssberg Lauridsen, Kaisa Huhtinen, et al.
Nature Communications|May 9, 2014
S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cellsJyoti K Jaiswal, Stine P Lauritzen, Luana Scheffer, et al.
Cancer Research|August 15, 2008
Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2Nicole Fehrenbacher, Lone Bastholm, Thomas Kirkegaard-Sørensen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 8, 2005
Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effectorBenny Björkblom, Nina Ostman, Vesa Hongisto, et al.
Frontiers in Pharmacology|June 20, 2022
Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate CancerThiago S Lima, Luciano O Souza, Diego Iglesias-Gato, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 3, 2021
Identification of lysosome-targeting drugs with anti-inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancersMalene Bredahl Hansen, Maria Postol, Siri Tvingsholm, et al.
Pageof 3